Faculty Bibliography

Epidemiologists found that a 48-year-old regular at a neighborhood bar in Minneapolis had infected at least 45 bartenders and other regular customers of the bar with TB. In turn, infected bar companions spread the infection to two others, including a seven-month-old child. The case is discussed in the New England Journal of Medicine on Jul 27, 1995

Although Senate Majority Leader Bob Dole has a number of physical handicaps and medical conditions, they are 'stable or controlled' and his health is 'excellent,' his doctors said on Jul 21, 1995. Based on checkups that Dole underwent in June and earlier in July, the medical records indicate that he is remarkably fit for a man of his age

A few hours after the chief neurosurgeon at Memorial Sloan-Kettering Cancer Center in New York City operated on the wrong side of a patient's brain on May 26, hospital officials knew he had made a horrendous error. The doctor had operated on the healthy part of the brain after looking at another patient's X-rays. Two weeks later, on June 10, after an initial inquiry, the cancer center suspended the doctor, Ehud Arbit, from his surgical and administrative duties. On June 21, and only in response to a reporter's inquiries, the hospital publicly acknowledged the error. Critics say that the main hospital accrediting agency, the Joint Commission on Accreditation of Healthcare Organizations in Oakbrook Terrace, Ill., is an unaggressive watchdog that announces most of its visits in advance and rarely bites anyone hard enough to leave a mark

A large number of preventable errors occur in US hospitals, and the mechanisms for quality control are not firmly enforced. Critics say that the main hospital accrediting agency, the Joint Commission on Accreditation of Healthcare Organizations, is an unaggressive watchdog. Richard Horton, editor of the Lancet, says there is a 'pervasive lack of accountability in medicine.'

A few hours after the chief neurosurgeon at Memorial Sloan-Kettering Cancer Center in New York City operated on the wrong side of a patient's brain May 26, hospital officials knew he had made a horrendous error. Two weeks later, on June 10, after an initial inquiry, the cancer center suspended the doctor, Ehud Arbit, from his surgical and administrative duties. On June 21, and only in response to a reporter's inquiries, the hospital publicly acknowledged the error. Critics say that the main hospital accrediting agency, the Joint Commission on Accreditation of Healthcare Organizations in Oakbrook Terrace, Ill., is an unaggressive watchdog that announces most of its visits in advance and rarely bites anyone hard enough to leave a mark

Treating HIV before it causes symptoms might delay its progression to AIDS but doesn't prolong a patient's survival, a new study says. The study Saturday in the Brit ish Medical Journal supports findings from a 1993 study in Europe that also called into question a standard practice of prescribing the drug AZT for people infected with HIV, the human immunodeficiency virus that causes AIDS. The authors of the new British study said they hoped it will raise more discussion about the relative merits of treating HIV early or after symptoms develop and stimulate scientists to focus more studies on the quality of life among those treated for HIV

The study, reported Saturday in the British Medical Journal, supports findings from the Concorde study in Europe that in 1993 called into question a standard practice of prescribing the drug AZT for people infected with HIV, or human immunodeficiency virus, which causes AIDS. The British study involved 436 AIDS patients at St. Mary's Hospital Medical School in London. Its authors said they hoped it would raise more discussion about the relative merits of treating HIV early or after symptoms develop and stimulate scientists to focus more studies on the quality of life among those treated for HIV-infection

Treatment of HIV infection before it causes symptoms may delay progression to AIDS but does not prolong survival, a new study has found. The study, reported Saturday in the British Medical Journal, supports findings from the Concorde study in Europe that in 1993 called into question a standard practice of prescribing the drug AZT for people infected with HIV, or human immunodeficiency virus, which causes AIDS. The British study involved 436 AIDS patients at St. Mary's Hospital Medical School in London. Its authors said they hoped it would raise more discussion about the relative merits of treating HIV early or after symptoms develop and stimulate scientists to focuson the quality of life among those treated for HIVinfection

Treatment of HIV infection before it causes symptoms may delay its progression to AIDS but does not prolong survival, a new study reported on Jul 15, 1995 in the British Medical Journal has found

WASHINGTON - Treatment of HIV infection before it causes symptoms may delay progression to AIDS but does not prolong survival, a new study has found. The study, reported yesterday in the British Medical Journal, supports findings from the Concorde study in Europe that in 1993 called into question a standard practice of prescribing the drug AZT for people infected with HIV, or human immunodeficiency virus, which causes AIDS. The British study involved 436 AIDS patients at St. Mary's Hospital Medical School in London